MRNA
Moderna, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -12.5% ·
Aktienfluss -3.8% ·
neue Nettopositionen -14.3%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +2 | 264.33M | $18.50B | +8 | −5 |
| Q1 2026 | 147 | +3 | 253.55M | $12.87B | +6 | −4 |
| Q4 2025 | 144 | +3 | 257.18M | $7.59B | +5 | −1 |
| Q3 2025 | 18 | +1 | 165.07M | $4.26B | +2 | −2 |
| Q2 2025 | 15 | 0 | 160.48M | $4.43B | +1 | −1 |
| Q1 2025 | 12 | -2 | 69.84M | $1.98B | +1 | −3 |
| Q4 2024 | 14 | -1 | 78.84M | $3.28B | +3 | −4 |
| Q3 2024 | 14 | -2 | 62.86M | $4.20B | +2 | −4 |
| Q2 2024 | 16 | — | 65.32M | $7.75B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 42.46M | -2.3% | $2.84B | 2.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 42.46M | -2.3% | $2.84B | 2.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 42.46M | -2.3% | $2.84B | 2.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 42.46M | -2.3% | $2.84B | 2.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 7.07M | +2.6% | $470.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 7.07M | +2.6% | $470.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 5.22M | +21.0% | $349.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (passiv) | 3.77M | +12.5% | $251.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.46M | -8.7% | $97.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.46M | -8.7% | $97.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 1.16M | +10.4% | $77.79M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 627.48K | +3138.3% | $41.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 310.30K | +261.2% | $20.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 259.12K | Neu | $17.32M | 0.0% | New | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 252.38K | -45.2% | $16.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Millennium Management ✦ | 150.32K | +205.5% | $10.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 102.90K | -59.2% | $6.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 6.26K | Neu | $418,729 | 0.0% | New | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 3.01K | -40.8% | $201,126 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 3.01K | -40.8% | $201,126 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| D. E. Shaw & Co. | $17.32M | 0.0% |
| Fisher Asset Management | $418,729 | 0.0% |
Ausgestiegen
| Capital World Investors | $435.48M | war 0.1% |
| Gotham Asset Management | $8.00M | war 0.1% |
| Marshall Wace | $4.18M | war 0.0% |
| Bridgewater Associates | $1.82M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 717 Inhaber, 306.78M Anteile, $15.39B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.